· PhD (Doctorat d'Etat Es-Sciences médicales)
in Experimental Oncology and Cancer Pharmacology from René-Descartes
and Lariboisiere/Sorbonne Universities in Paris, and the National Cancer Institute
at Villejuif, France
· Specialized diploma in Cancer Pharmacology and Genetic Toxicology,
Rene-Descartes and Lariboisiere/Sorbonne Universities in Paris
· Specialized degree in General Oncology, Paris-Sud Krémlin
Bicetre University of Medicine, Paris
· Postdoctoral training at the Cancer Center of the Roswell Park Memorial
Institute in Buffalo, NY, USA.
· Present position: Professor, Departments of Medicine/Oncology and
the Cancer Centre
at McGill University; Director of the laboratory of Cancer Pharmacogenomics
& Target Discovery at the Lady Davis Institute of the Jewish General Hospital;
Leader, Drug Discovery Program, Montreal Centre for Experimental Therapeutics
in Cancer
· Member of the Centres for Translational Research in Cancer and Neuroscience
Awards
Research Scholar (chercheur national), Fonds de la Recherche en Santé du Québec (FRSQ); Dundi and Lyon Sachs Distinguished Scientist, Jewish General Hospital